Update on coronavirus disease 2019 : Ophthalmic Manifestations and Adverse Reactions to Vaccination
Copyright © 2023 Asia-Pacific Academy of Ophthalmology. Published by Wolters Kluwer Health, Inc. on behalf of the Asia-Pacific Academy of Ophthalmology..
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 was one of the most devastating public health issues in recent decades. The ophthalmology community is as concerned about the COVID-19 pandemic as the global public health community is, as COVID-19 was recognized to affect multiple organs in the human body, including the eyes, early in the course of the outbreak. Ophthalmic manifestations of COVID-19 are highly variable and could range from mild ocular surface abnormalities to potentially sight and life-threatening orbital and neuro-ophthalmic diseases. Furthermore, ophthalmic manifestations may also be the presenting or the only findings in COVID-19 infections. Meanwhile, global vaccination campaigns to attain herd immunity in different populations are the major strategy to mitigate the pandemic. As novel vaccinations against COVID-19 emerged, so were reports on adverse ophthalmic reactions potentially related to such. As the world enters a post-pandemic state where COVID-19 continues to exist and evolve as an endemic globally, the ophthalmology community ought to be aware of and keep abreast of the latest knowledge of ophthalmic associations with COVID-19 and its vaccinations. This review is a summary of the latest literature on the ophthalmic manifestations of COVID-19 and the adverse ophthalmic reactions related to its vaccinations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) - 12(2023), 6 vom: 01. Nov., Seite 512-536 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lin, Timothy P H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.12.2023 Date Revised 24.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/APO.0000000000000647 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366082809 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366082809 | ||
| 003 | DE-627 | ||
| 005 | 20240124232024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/APO.0000000000000647 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1269.xml |
| 035 | |a (DE-627)NLM366082809 | ||
| 035 | |a (NLM)38117598 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lin, Timothy P H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Update on coronavirus disease 2019 |b Ophthalmic Manifestations and Adverse Reactions to Vaccination |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2023 | ||
| 500 | |a Date Revised 24.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Asia-Pacific Academy of Ophthalmology. Published by Wolters Kluwer Health, Inc. on behalf of the Asia-Pacific Academy of Ophthalmology. | ||
| 520 | |a The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 was one of the most devastating public health issues in recent decades. The ophthalmology community is as concerned about the COVID-19 pandemic as the global public health community is, as COVID-19 was recognized to affect multiple organs in the human body, including the eyes, early in the course of the outbreak. Ophthalmic manifestations of COVID-19 are highly variable and could range from mild ocular surface abnormalities to potentially sight and life-threatening orbital and neuro-ophthalmic diseases. Furthermore, ophthalmic manifestations may also be the presenting or the only findings in COVID-19 infections. Meanwhile, global vaccination campaigns to attain herd immunity in different populations are the major strategy to mitigate the pandemic. As novel vaccinations against COVID-19 emerged, so were reports on adverse ophthalmic reactions potentially related to such. As the world enters a post-pandemic state where COVID-19 continues to exist and evolve as an endemic globally, the ophthalmology community ought to be aware of and keep abreast of the latest knowledge of ophthalmic associations with COVID-19 and its vaccinations. This review is a summary of the latest literature on the ophthalmic manifestations of COVID-19 and the adverse ophthalmic reactions related to its vaccinations | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Sen, Mrittika |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vishali |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Rupesh |e verfasserin |4 aut | |
| 700 | 1 | |a Lanzetta, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Giannaccare, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Carmen K M |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Kajal |e verfasserin |4 aut | |
| 700 | 1 | |a Menia, Nitin Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Rojas-Carabali, William |e verfasserin |4 aut | |
| 700 | 1 | |a Arora, Atul |e verfasserin |4 aut | |
| 700 | 1 | |a Martinuzzi, Deborah |e verfasserin |4 aut | |
| 700 | 1 | |a Taloni, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Rubinato, Leopoldo |e verfasserin |4 aut | |
| 700 | 1 | |a Coco, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Sarao, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Veritti, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Lizhen |e verfasserin |4 aut | |
| 700 | 1 | |a Honavar, Santosh G |e verfasserin |4 aut | |
| 700 | 1 | |a Lam, Dennis S C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) |d 2012 |g 12(2023), 6 vom: 01. Nov., Seite 512-536 |w (DE-627)NLM230518826 |x 2162-0989 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:6 |g day:01 |g month:11 |g pages:512-536 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/APO.0000000000000647 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 6 |b 01 |c 11 |h 512-536 | ||